2013-12-11 01:41:13 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Medical Action Industries (MDCI) and produced a report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering Medical Action Industries (MDCI). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Medical Action Industries investor.
Report Summary: Medical Action Industries is a low quality company with a neutral outlook. Medical Action Industries has strong business growth and is run by inefficient management. The trend in Medical Action Industries fair value exchange rate against its closest rated-competitor, Symmetry Medical Inc., has been appreciating over the past 2 weeks. When compared to its closest competitor, Medical Action Industries shows similar overvaluation and is equally likely to underperform the market.
The report breaks down the Total StockMark into its three
components - business, management and price, performing an in-depth analysis of Medical Action Industries for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext and from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, One source West Services, and Dow Jones/Factiva.
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering 31 different markets and over 22,000 companies. The StockMarks rating system is based on proven investment principles and is designed to drive long-term shareholder returns.